Condition
Chronic Venous Leg Ulcers
Total Trials
5
Recruiting
0
Active
0
Completed
1
Success Rate
50.0%-37% vs avg
Key Insights
Highlights
Success Rate
50% trial completion
Clinical Risk Assessment
Based on trial outcomes
High Risk
Score: 65/100
Termination Rate
20.0%
1 terminated out of 5 trials
Success Rate
50.0%
-36.5% vs benchmark
Late-Stage Pipeline
40%
2 trials in Phase 3/4
Results Transparency
0%
0 of 1 completed with results
Key Signals
50% success
Data Visualizations
Phase Distribution
5Total
Not Applicable (1)
P 1 (1)
P 2 (1)
P 3 (1)
P 4 (1)
Trial Status
Unknown3
Terminated1
Completed1
Trial Success Rate
50.0%
Benchmark: 86.5%
Based on 1 completed trials
Clinical Trials (5)
Showing 5 of 5 trials
NCT03576989Not ApplicableCompletedPrimary
Impact of Omega-3 Fatty Acid Oral Therapy on Healing of Chronic Venous Leg Ulcers in Older Adults
NCT02936128Phase 4TerminatedPrimary
TruSkin®: Study for Treatment of Chronic Venous Leg Ulcers
NCT02130310Phase 3UnknownPrimary
Evaluation of CureXcell® in Treating Chronic Venous Leg Ulcers
NCT00797706Phase 1UnknownPrimary
Phase I/II Dose Ranging CHRONSEAL® Study in Venous Leg Ulcers
NCT00678847Phase 2UnknownPrimary
Chronic Venous ULcer TReatment Analyzing Bio-Electrical Stimulation Therapy
Showing all 5 trials